Botanical species · safety record

Vitis rotundifolia

The EFSA Compendium of Botanicals holds 2 constituent measurements and 2 adverse-effect records for Vitis rotundifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Vitis rotundifolia Michx.

2Constituent measurements
2Safety records
3Cited sources
19Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 19 licensed products naming Vitis rotundifolia as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Fruit
  • Fruit skin
  • New material
  • Seed
  • Seed skin
  • Seed(s)
  • Skin
  • fruit and seeds

What the records describe

Constituents measured

  • Gallic acid1
  • Tannins1

Plant parts

  • Fruit unspecified3
  • Live plants1

Preparations

  • Solvent extraction4

Effect types

  • Digestive2

Target tissues

  • Digestive: pancreas2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Gallic acidFruit unspecifiedSolvent extractionHPLC with standard detection methodsResolve DOI
TanninsLive plantsSolvent extractionPhytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestive: pancreasFruit unspecifiedSolvent extractionIn vitroResolve DOI
DigestiveDigestive: pancreasFruit unspecifiedSolvent extractionIn vitroResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Lee, J.-H., Johnson, J.V., Talcott, S.T. Identification of ellagic acid conjugates and other polyphenolics in muscadine grapes by HPLC-ESI-MS. Journal of Agricultural and Food Chemistry, 2005, vol. 53, no. 15, p. 6003-6010. DOI
  2. Worthley, Elmer G., Schott, C. Donald. Biologically-active compounds in some flowering plants. Life sciences, 1969, p. 225-238.
  3. You, Q., Chen, F., Wang, X., Luo, P.G., Jiang, Y. Inhibitory effects of muscadine anthocyanins on alpha-glucosidase and pancreatic lipase activities. Journal of agricultural and food chemistry, 2011, vol. 59, no. 17, p. 9506-9511. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue